|
| Status |
Public on Feb 28, 2022 |
| Title |
1_13 |
| Sample type |
protein |
| |
|
| Source name |
sJIA/severe ILD
|
| Organism |
Homo sapiens |
| Characteristics |
tissue: serum
patient_id: 118
disease: sJIA-LD
Sex: M
age(year): 4.7
hospital: NIH
sample quality hemolysis score: 0
|
| Extracted molecule |
protein |
| Extraction protocol |
not provided
|
| Label |
N/A
|
| Label protocol |
Somalogic standard protocol
|
| |
|
| Hybridization protocol |
Somalogic standard protocol
|
| Scan protocol |
Somalogic standard protocol
|
| Description |
We used SOMAscan to measure >1300 analytes in sera from healthy controls and patients with sJIA, MAS, sJIA-LD and other related diseases.
1_13
|
| Data processing |
Post-normalization, all samples met predefined acceptance criteria and were included in the analysis. A complete description of the normalization and calibration procedures is available at: www.somalogic.com/wp-content/uploads/2017/03/SSM-071-Rev-0-Technical-Note-SOMAscan-Data-Standardization.pdf.
|
| |
|
| Submission date |
Feb 27, 2022 |
| Last update date |
Feb 28, 2022 |
| Contact name |
Scott Canna |
| E-mail(s) |
cannas@chop.edu
|
| Organization name |
Children's Hospital of Philadelphia
|
| Street address |
The Children’s Hospital of Philadelphia Department of Pediatrics Philadelphia
|
| City |
Philadelphia |
| ZIP/Postal code |
19104 |
| Country |
USA |
| |
|
| Platform ID |
GPL23119 |
| Series (1) |
| GSE197546 |
Serum proteome analysis of systemic JIA and related lung disease identifies distinct inflammatory programs and biomarkers |
|
